Literature DB >> 22941425

The influence of the API properties on the ODTs manufacturing from co-processed excipient systems.

Anna Krupa1, Renata Jachowicz, Zbigniew Pędzich, Krystyna Wodnicka.   

Abstract

Directly compressible co-processed excipient systems facilitate orodispersible tablets (ODTs) manufacturing. Despite several excipient systems available, it is reported that the incorporation of high drug dose into the tablet mass may negatively affect both disintegration and mechanical properties. Therefore the influence of drug properties on the quality of orodispersible tablets was investigated. Fast dissolving tablet matrix was made of a co-processed excipient system F-Melt. Two grades of F-Melt that differed in composition, particle shape, and specific surface area were used to form tablet matrix. Ibuprofen, diclofenac sodium, and diltiazem hydrochloride were chosen as model drugs of different physicochemical properties such as solubility, particle size, and shape. Ninety formulations containing 12.5, 25, or 50 wt% of the model drug and F-Melt type C or M were prepared by direct compression. The quality of tablets was examined on the base of disintegration time, wetting time, mechanical resistance and texture analysis. The results showed that F-Melt grade, drug solubility, and its dose had an influence on the quality of tablets. From ninety formulations prepared, only four batches containing F-Melt type C and 12.5 wt% of ibuprofen, diclofenac sodium, or diltiazem hydrochloride could be classified as ODTs. Their disintegration time ranged from 41 to 144 s. In the case of F-Melt type M, tablets disintegrating within 101 s of friability below 1% could be prepared only if 12.5 wt% of diclofenac sodium was incorporated into the tablet mass.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22941425      PMCID: PMC3513440          DOI: 10.1208/s12249-012-9831-2

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  9 in total

1.  Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets.

Authors:  Dina Nath Mishra; Madhu Bindal; Shailendra Kumar Singh; Sengodan Gurusamy Vijaya Kumar
Journal:  Chem Pharm Bull (Tokyo)       Date:  2006-01       Impact factor: 1.645

Review 2.  Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies.

Authors:  Yourong Fu; Shicheng Yang; Seong Hoon Jeong; Susumu Kimura; Kinam Park
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2004       Impact factor: 4.889

Review 3.  A review of co-processed directly compressible excipients.

Authors:  M C Gohel; Pranav D Jogani
Journal:  J Pharm Pharm Sci       Date:  2005-04-16       Impact factor: 2.327

4.  Development of fast disintegrating compressed tablets using amino acid as disintegration accelerator: evaluation of wetting and disintegration of tablet on the basis of surface free energy.

Authors:  Jinichi Fukami; Asuka Ozawa; Yasuo Yoshihashi; Etsuo Yonemochi; Katsuhide Terada
Journal:  Chem Pharm Bull (Tokyo)       Date:  2005-12       Impact factor: 1.645

5.  Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.

Authors:  Jinichi Fukami; Etsuo Yonemochi; Yasuo Yoshihashi; Katsuhide Terada
Journal:  Int J Pharm       Date:  2006-01-23       Impact factor: 5.875

6.  Development of an easily swallowed film formulation.

Authors:  Hideaki Okabe; Eiji Suzuki; Yusaku Sugiura; Kaisuke Yanagimoto; Yasunari Takanashi; Masaru Hoshi; Eiji Nogami; Kaname Nakahara; Toru Sekiguchi; Mikoto Baba; Eiichi Saitoh
Journal:  Int J Pharm       Date:  2007-11-29       Impact factor: 5.875

7.  Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.

Authors:  Y Bi; H Sunada; Y Yonezawa; K Danjo; A Otsuka; K Iida
Journal:  Chem Pharm Bull (Tokyo)       Date:  1996-11       Impact factor: 1.645

8.  Preparation and characterization of a novel co-processed excipient of chitin and crystalline mannitol.

Authors:  Nidal Daraghmeh; Iyad Rashid; Mahmoud M H Al Omari; Stephen A Leharne; Babur Z Chowdhry; Adnan Badwan
Journal:  AAPS PharmSciTech       Date:  2010-11-04       Impact factor: 3.246

9.  Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol.

Authors:  Yoshio Kuno; Masazumi Kojima; Hiroaki Nakagami; Etsuo Yonemochi; Katsuhide Terada
Journal:  Eur J Pharm Biopharm       Date:  2008-02-23       Impact factor: 5.571

  9 in total
  4 in total

1.  A Comparative Study of Different Proportions of Superdisintegrants: Formulation and Evaluation of Orally Disintegrating Tablets of Salbutamol Sulphate.

Authors:  Ajay Kumar; Vikas Anand Saharan
Journal:  Turk J Pharm Sci       Date:  2017-04-15

2.  Evaluation and Comparison of Three Types of Spray Dried Coprocessed Excipient Avicel® for Direct Compression.

Authors:  Pavlína Vodáčková; Barbora Vraníková; Petra Svačinová; Aleš Franc; Jan Elbl; Jan Muselík; Roman Kubalák; Tomaš Solný
Journal:  Biomed Res Int       Date:  2018-04-19       Impact factor: 3.411

3.  Puzzle out Machine Learning Model-Explaining Disintegration Process in ODTs.

Authors:  Jakub Szlęk; Mohammad Hassan Khalid; Adam Pacławski; Natalia Czub; Aleksander Mendyk
Journal:  Pharmaceutics       Date:  2022-04-13       Impact factor: 6.525

4.  Development of orally disintegrating tablets containing solid dispersion of a poorly soluble drug for enhanced dissolution: In-vitro optimization/in-vivo evaluation.

Authors:  Shahinaze A Fouad; Fady A Malaak; Mohamed A El-Nabarawi; Khalid Abu Zeid
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.